Literature DB >> 25749095

Retinoic acid-induced IgG production in TLR-activated human primary B cells involves ULK1-mediated autophagy.

Agnete Bratsberg Eriksen1, Maria Lyngaas Torgersen, Kristine Lillebø Holm, Greger Abrahamsen, Anne Spurkland, Jan Øivind Moskaug, Anne Simonsen, Heidi Kiil Blomhoff.   

Abstract

In the present study we have established a vital role of autophagy in retinoic acid (RA)-induced differentiation of toll-like receptor (TLR)-stimulated human B cells into Ig-secreting cells. Thus, RA enhanced autophagy in TLR9- and CD180-stimulated peripheral blood B cells, as revealed by increased levels of the autophagosomal marker LC3B-II, enhanced colocalization between LC3B and the lysosomal marker Lyso-ID, by a larger percentage of cells with more than 5 characteristic LC3B puncta, and by the concomitant reduction in the level of SQSTM1/p62. Furthermore, RA induced expression of the autophagy-inducing protein ULK1 at the transcriptional level, in a process that required the retinoic acid receptor RAR. By inhibiting autophagy with specific inhibitors or by knocking down ULK1 by siRNA, the RA-stimulated IgG production in TLR9- and CD180-mediated cells was markedly reduced. We propose that the identified prominent role of autophagy in RA-mediated IgG-production in normal human B cells provides a novel mechanism whereby vitamin A exerts its important functions in the immune system.

Entities:  

Keywords:  ATG, autophagy-related; B lymphocytes; BDS, bright detail similarity; CD180; CD180, CD180 molecule; CVID, common variable immune deficiency; ELISA, enzyme-linked immunosorbent assay; IL, interleukin; Ig, immunoglobulin; MAP1LC3B/LC3B, microtubule-associated protein 1 light chain 3 β; MTOR, mechanistic target of rapamycin (serine/threonine kinase); PAMP, pathogen-associated molecular pattern, PML/RARA, promyelocytic leukemia/ retinoic acid receptor α; RA, all-trans retinoic acid; RAR, retinoic acid receptor; RP105; SQSTM1, sequestosome 1; TLR, toll-like receptor; TLR9; ULK1; ULK1, unc-51 like autophagy activating kinase 1; antibody secretion; autophagy; plasma cell differentiation; retinoic acid

Mesh:

Substances:

Year:  2015        PMID: 25749095      PMCID: PMC4502696          DOI: 10.1080/15548627.2015.1009797

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  56 in total

1.  MatInspector and beyond: promoter analysis based on transcription factor binding sites.

Authors:  K Cartharius; K Frech; K Grote; B Klocke; M Haltmeier; A Klingenhoff; M Frisch; M Bayerlein; T Werner
Journal:  Bioinformatics       Date:  2005-04-28       Impact factor: 6.937

2.  Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy.

Authors:  Isei Tanida; Naoko Minematsu-Ikeguchi; Takashi Ueno; Eiki Kominami
Journal:  Autophagy       Date:  2005-07-31       Impact factor: 16.016

3.  Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK.

Authors:  Aase Ertesvag; Hans-Christian Aasheim; Soheil Naderi; Heidi Kiil Blomhoff
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

4.  Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9.

Authors:  Liliana Busconi; Jason W Bauer; Joseph R Tumang; Amy Laws; Kristin Perkins-Mesires; Abigail S Tabor; Christina Lau; Ronald B Corley; Thomas L Rothstein; Frances E Lund; Timothy W Behrens; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

Review 5.  Autophagy: from phenomenology to molecular understanding in less than a decade.

Authors:  Daniel J Klionsky
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

Review 6.  Overview of retinoid metabolism and function.

Authors:  Rune Blomhoff; Heidi Kiil Blomhoff
Journal:  J Neurobiol       Date:  2006-06

7.  The role of autophagy during the early neonatal starvation period.

Authors:  Akiko Kuma; Masahiko Hatano; Makoto Matsui; Akitsugu Yamamoto; Haruaki Nakaya; Tamotsu Yoshimori; Yoshinori Ohsumi; Takeshi Tokuhisa; Noboru Mizushima
Journal:  Nature       Date:  2004-11-03       Impact factor: 49.962

Review 8.  Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivo.

Authors:  A Catharine Ross
Journal:  Vitam Horm       Date:  2007       Impact factor: 3.421

9.  The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens.

Authors:  Akanksha Chaturvedi; David Dorward; Susan K Pierce
Journal:  Immunity       Date:  2008-05-29       Impact factor: 31.745

10.  p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death.

Authors:  Geir Bjørkøy; Trond Lamark; Andreas Brech; Heidi Outzen; Maria Perander; Aud Overvatn; Harald Stenmark; Terje Johansen
Journal:  J Cell Biol       Date:  2005-11-14       Impact factor: 10.539

View more
  13 in total

1.  Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis.

Authors:  Kristine L Holm; Randi L Indrevaer; June Helen Myklebust; Arne Kolstad; Jan Øivind Moskaug; Elin H Naderi; Heidi K Blomhoff
Journal:  Immunology       Date:  2016-07-25       Impact factor: 7.397

2.  Retinoic acid can improve autophagy through depression of the PI3K-Akt-mTOR signaling pathway via RARα to restore spermatogenesis in cryptorchid infertile rats.

Authors:  Chunlan Long; Yu Zhou; Lianju Shen; Yihang Yu; Dong Hu; Xing Liu; Tao Lin; Dawei He; Tao Xu; Deying Zhang; Jing Zhu; Guanghui Wei
Journal:  Genes Dis       Date:  2021-04-02

3.  An Integrative Framework Reveals Signaling-to-Transcription Events in Toll-like Receptor Signaling.

Authors:  Philipp Mertins; Dariusz Przybylski; Nir Yosef; Jana Qiao; Karl Clauser; Raktima Raychowdhury; Thomas M Eisenhaure; Tanja Maritzen; Volker Haucke; Takashi Satoh; Shizuo Akira; Steven A Carr; Aviv Regev; Nir Hacohen; Nicolas Chevrier
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

Review 4.  Roles of Autophagy and Autophagy-Related Proteins in Antifungal Immunity.

Authors:  Masashi Kanayama; Mari L Shinohara
Journal:  Front Immunol       Date:  2016-02-18       Impact factor: 7.561

5.  The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway.

Authors:  Zhen-Hua Chen; Wen-Tao Wang; Wei Huang; Ke Fang; Yu-Meng Sun; Shu-Rong Liu; Xue-Qun Luo; Yue-Qin Chen
Journal:  Cell Death Differ       Date:  2016-10-14       Impact factor: 15.828

Review 6.  Control of Innate and Adaptive Lymphocytes by the RAR-Retinoic Acid Axis.

Authors:  Chang H Kim
Journal:  Immune Netw       Date:  2018-01-18       Impact factor: 6.303

7.  Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells.

Authors:  Eleonora Fonte; Maria Giovanna Vilia; Daniele Reverberi; Ilenia Sana; Lydia Scarfò; Pamela Ranghetti; Ugo Orfanelli; Simone Cenci; Giovanna Cutrona; Paolo Ghia; Marta Muzio
Journal:  Haematologica       Date:  2017-08-03       Impact factor: 9.941

8.  [Changes in autophagy during maturation and differentiation of Hepa1-6 cells induced by all-trans retinoic acid].

Authors:  Shu-Yu Fang; Jie-Jie Cui; Meng-Jia Gong; Yun He; Jing-Fang Zhang; Yang Bi
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

Review 9.  Long non-coding RNAs involved in autophagy regulation.

Authors:  Lixian Yang; Hanying Wang; Qi Shen; Lifeng Feng; Hongchuan Jin
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

10.  cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53.

Authors:  Seham Skah; Nina Richartz; Eva Duthil; Karin M Gilljam; Christian Bindesbøll; Elin Hallan Naderi; Agnete B Eriksen; Ellen Ruud; Marta M Dirdal; Anne Simonsen; Heidi Kiil Blomhoff
Journal:  Oncotarget       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.